Home > Clinical Resources > Liver >
First published on 20 Nov 2018
Quality and Productivity: Proven Case Study Alcohol care teams: reducing acute hospital admissions and improving quality of care Provided by: The British Society of Gastroenterology and Bolton NHS Foundation Trust Publication type: Quality and productivity example Sharing good practice: What […]
First published on 20 Nov 2018
Executive Summary Alcohol misuse and alcohol‐related problems, especially binge drinking and alcohol-related liver disease, are major public health concerns. Recently, much attention has focused on social policy and measures to reduce drinking. There is an additional need to provide care […]
First published on 05 Apr 2018
Dear Liver Section members, I am writing to inform you of a significant caution about the use of ulipristal acetate (Esmya). Esmya is indicated for the pre-operative and intermittent treatment of moderate to severe symptoms of uterine fibroids in women […]
First published on 21 Feb 2018
Evidence-based recommendations on sofosbuvir–velpatasvir–voxilaprevir (Vosevi) for treating chronic hepatitis C in adults.
First published on 01 Feb 2016
These recommendations were developed at a consensus meeting of clinicians and interested parties on 5 January 2016. Therapies that are NICE approved are presented in bold and those that are NICE unapproved are italicised. The prices of the different regimens […]
First published on 25 Nov 2015
NICE technology appraisal guidance [TA364] Published date: November 2015
First published on 25 Nov 2015
First published on 25 Oct 2015
NICE technology appraisal guidance [TA365] Published date: November 2015
First published on 22 Oct 2015
22nd October 2015 NHS England has published the service specification for Operational Delivery Networks (ODNs) for hepatitis C care in adults. The full document is available below. Many BSG members will have been involved in the set up processes to date […]